-
Assessment of fatigue and nutritional status in patients with multiple sclerosis
Vol 1, 2023 - -
Anti-CD20 therapy in Multiple Sclerosis: real-word data from a single-center in Northeast Brazil
Vol 1, 2023 - -
Bicams as a method of identifying cognitive decline in Multiple Sclerosis patients in a northeast MS reference center
Vol 1, 2023 - -
CLINICAL PROFILE OF MULTIPLE SCLEROSIS PATIENTS AT FIRST NURSING CARE IN A NORTHEAST SPECIALIZED MS CENTER
Vol 1, 2023 - -
Cognitive Decline as Early Manifestation of Multiple Sclerosis: A Case Series
Vol 1, 2023 -
Publications in other proceedings
-
BCTRIMS 2024
Exit strategies in Natalizumab: the dilemma in limited resource scenarios.
-
BCTRIMS 2024
DISABILITY FUNCTIONAL PROFILE OF PATIENTS WITH PROGRESSIVE MULTIPLE SCLEROSIS AND ITS ASSOCIATION WITH DISEASE MODIFYING THERAPY IN A HOSPITAL AT NORTHEAST OF BRAZIL
-
BCTRIMS 2024
Correlations between Multiple Sclerosis, Cognition, Human Development Index, and Social Vulnerability.
-
BCTRIMS 2024
REHABILITATION ACCESS PROFILE OF PATIENTS WITH PROGRESSIVE MULTIPLE SCLEROSIS IN REFERENCE CENTER AT NORTHEAST BRAZIL
-
BCTRIMS 2024
Evaluation of neuromyelitis optica spectrum disorder in patients under Rituximab and applicability of no responsiveness criteria for first-line therapies: A real-world data in resources limited settings
Streamline your Scholarly Event
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
